Collectively, these clinical and in vivo findings demonstrate that CD73 is markedly upregulated in EGFR‐mutant NSCLC, and this aberrant expression not only predicts poor prognosis but also contributes to immunosuppressive remodeling of the TME. This evidence concerns the gene EGFR and non-small cell lung carcinoma.